Healthcare
GoodRx Holdings, Inc.(GDRX)
Live Price
Offline$2.61
-4.40% today
1Y Change
-46.84%
Window
Jun 25, 2025 โ Jun 17, 2026
- Market Cap
- $800.00M
- Revenue Growth
- +0.6%
- EPS Growth
- +100.9%
- Dividend Yield
- 0.0%
Coverage: 246 bars ยท Jun 25, 2025 โ Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
GoodRx Holdings, Inc. (GDRX) is a Healthcare stock with a market cap of $800.00M and listed on NASDAQ. The stock last traded around $2.61 and down 46.8% across the available one-year price window (Jun 25, 2025 โ Jun 17, 2026). Baseline metrics include revenue growth of +0.6%, EPS growth of +100.9%, a dividend yield of 0.0%. What stands out right now is revenue +0.6%, EPS +100.9%, free cash flow +44.8% with operating margin 11.2% and ROIC 4.1%. Valuation is more restrained than many high-expectation growth names at P/E 26.1 and price/sales 1.0. Stock Foundry combines GDRX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
+0.6% vs +7.6% peer median
Operating Margin
Below sector median
+11.2% vs +19.4% peer median
P/E
Below sector median
26.1 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 6, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +0.6% and EPS at +100.9%, with operating margin around 11.2%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -5.5% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 6, 2026 | โ | +10.5% | +1.6% | +10.9% |
2026 Feb 25, 2026 | +0.0% | -18.8% | -11.0% | -15.9% |
2025 Nov 4, 2025 | -11.1% | +2.1% | -7.1% | -16.0% |
Benchmark Edge
GDRX vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
GDRX
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
GDRX Max Drawdown
-63.48%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for GDRX and SPY.
Company Overview
GoodRx Holdings, Inc.
NASDAQ Global Select
GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including subscriptions, pharma manufacturer solutions, and telehealth services. It serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was incorporated in 2015 and is headquartered in Santa Monica, California.
- Leadership
- Wendy Barnes
- IPO Date
- Sep 23, 2020
- Employees
- 738
- Street Address
- 2701 Olympic Boulevard
- Mailing
- Santa Monica, CA, 90404
- Region
- Santa Monica, CA, US
- Reporting Currency
- USD
- Investor Line
- 855 268 2822
- Last Updated
- Apr 29, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 26.1
- EV/EBITDA
- 3.2
- Price/Sales
- 1.0
- Price/Book
- 1.3
Growth
- Revenue
- +0.6%
- EPS
- +100.9%
- Free Cash Flow
- +44.8%
Profitability
- Gross Margin
- 82.1%
- Operating Margin
- 11.2%
- Net Margin
- 3.8%
- ROE
- 4.8%
- ROIC
- 4.1%
Balance Sheet
- Debt/Equity
- 0.10
- Current Ratio
- 2.61
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.